Compounds > n-(3-pyridylmethyl)adriamycin
Page last updated: 2024-09-05

n-(3-pyridylmethyl)adriamycin and Neoplasms

n-(3-pyridylmethyl)adriamycin has been researched along with Neoplasms in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Blair, LJ; Cheng, JQ; Dickey, CA; Gestwicki, JE; Guo, J; Jinwal, UK; Kiray, J; Koren, J; Li, X; Miyata, Y; Nguyen, L; O'Leary, JC1

Other Studies

1 other study(ies) available for n-(3-pyridylmethyl)adriamycin and Neoplasms

ArticleYear
Rhodacyanine derivative selectively targets cancer cells and overcomes tamoxifen resistance.
    PloS one, 2012, Volume: 7, Issue:4

    Topics: Cell Line, Tumor; Cell Survival; Doxorubicin; Drug Resistance, Neoplasm; Estrogen Receptor alpha; HEK293 Cells; HeLa Cells; Humans; Neoplasms; Phosphorylation; Proto-Oncogene Proteins c-akt; Pyridinium Compounds; Tamoxifen; Thiazoles

2012